Bio-Works Technologies AB (publ)

NGM:BIOWKS Stock Report

Market Cap: SEK 91.6m

Bio-Works Technologies Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Bio-Works Technologies.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Medical Equipment earnings growth24.6%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

Recent updates

Companies Like Bio-Works Technologies (STO:BIOWKS) Are In A Position To Invest In Growth

Dec 25
Companies Like Bio-Works Technologies (STO:BIOWKS) Are In A Position To Invest In Growth

Companies Like Bio-Works Technologies (STO:BIOWKS) Are In A Position To Invest In Growth

Aug 30
Companies Like Bio-Works Technologies (STO:BIOWKS) Are In A Position To Invest In Growth

We Think Bio-Works Technologies (STO:BIOWKS) Can Afford To Drive Business Growth

Feb 21
We Think Bio-Works Technologies (STO:BIOWKS) Can Afford To Drive Business Growth

We Think Bio-Works Technologies (STO:BIOWKS) Can Afford To Drive Business Growth

Oct 25
We Think Bio-Works Technologies (STO:BIOWKS) Can Afford To Drive Business Growth

We Think Bio-Works Technologies (STO:BIOWKS) Can Easily Afford To Drive Business Growth

May 10
We Think Bio-Works Technologies (STO:BIOWKS) Can Easily Afford To Drive Business Growth

Bio-Works Technologies (STO:BIOWKS) Is In A Strong Position To Grow Its Business

Sep 27
Bio-Works Technologies (STO:BIOWKS) Is In A Strong Position To Grow Its Business

Is Bio-Works Technologies (STO:BIOWKS) In A Good Position To Invest In Growth?

May 11
Is Bio-Works Technologies (STO:BIOWKS) In A Good Position To Invest In Growth?

Bio-Works Technologies AB (publ) (STO:BIOWKS) Insiders Have Been Selling

Mar 20
Bio-Works Technologies AB (publ) (STO:BIOWKS) Insiders Have Been Selling

How Much Are Bio-Works Technologies AB (publ) (STO:BIOWKS) Insiders Taking Off The Table?

Dec 05
How Much Are Bio-Works Technologies AB (publ) (STO:BIOWKS) Insiders Taking Off The Table?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Bio-Works Technologies has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

NGM:BIOWKS - Analysts future estimates and past financials data (SEK Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202344-57-60-59N/A
9/30/202345-54-50-49N/A
6/30/202345-50-41-40N/A
3/31/202343-48-41-40N/A
12/31/202241-45-41-40N/A
9/30/202238-45-45-45N/A
6/30/202234-45-50-49N/A
3/31/202245-29-32-31N/A
12/31/202156-13-14-13N/A
9/30/202150-14-14-13N/A
6/30/202144-15-13-12N/A
3/31/202125-29-28-28N/A
12/31/20207-45-44-43N/A
9/30/20207-421718N/A
6/30/20207-421919N/A
3/31/20207-45-44-44N/A
12/31/20196-42-40-40N/A
9/30/20196-55-101-100N/A
6/30/20195-51-98-98N/A
3/31/20195-41-35-34N/A
12/31/20187-38-35-35N/A
9/30/20186-25-33-32N/A
6/30/20186-22-32-31N/A
3/31/20187-26-27-25N/A
12/31/20176-24-23-21N/A
9/30/20176-20N/A-16N/A
12/31/20166-17N/A-14N/A
12/31/20153-12N/A-13N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if BIOWKS's forecast earnings growth is above the savings rate (1.1%).

Earnings vs Market: Insufficient data to determine if BIOWKS's earnings are forecast to grow faster than the Swedish market

High Growth Earnings: Insufficient data to determine if BIOWKS's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if BIOWKS's revenue is forecast to grow faster than the Swedish market.

High Growth Revenue: Insufficient data to determine if BIOWKS's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if BIOWKS's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.